| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/19/2001 | EP1162963A1 Means for diagnosing and treating carcinoma |
| 12/19/2001 | EP1162961A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
| 12/19/2001 | EP1162960A2 Pharmaceutical compositions for the treatment of posttraumatic stress disorder |
| 12/19/2001 | EP1162959A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 12/19/2001 | EP1162957A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof |
| 12/19/2001 | EP1162954A1 Novel formulations comprising lipid-regulating agents |
| 12/19/2001 | EP1162949A1 Urethane surfactants and their use in personal care formulations |
| 12/19/2001 | EP1162946A1 Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained |
| 12/19/2001 | EP1162945A1 Particle based vaccine composition |
| 12/19/2001 | EP1162937A1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration |
| 12/19/2001 | EP1162890A1 A method of preventing parturient hypocalcemia in animals and compositions used therein |
| 12/19/2001 | EP1162884A1 Oral low dose butyrate compositions |
| 12/19/2001 | EP1162883A1 Oral anti-odor compositions |
| 12/19/2001 | EP1128726A4 Teat disinfectant |
| 12/19/2001 | EP1123100A4 Improving memory by the administration of delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof |
| 12/19/2001 | EP1102592A4 Coumarin and related aromatic-based polymeric prodrugs |
| 12/19/2001 | EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 12/19/2001 | EP1086109A4 Process for preparing crystalline salts of amoxycillin |
| 12/19/2001 | EP1085920B1 Dextrin-containing composition for preventing surgical adhesions |
| 12/19/2001 | EP1033978B1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 12/19/2001 | EP1014965A4 Dietary compositions for enhancing metabolism and alleviating oxidative stress |
| 12/19/2001 | EP0983063B1 Pharmaceutical composition containing uscharin |
| 12/19/2001 | EP0980349B1 Process for producing conjugated linolenic acid-based synthetic triglycerides |
| 12/19/2001 | EP0971717B1 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles |
| 12/19/2001 | EP0957920B1 Reducing toxic effects of carboplatin using dithioethers |
| 12/19/2001 | EP0914098A4 Multi-layered osmotic device |
| 12/19/2001 | EP0912573B1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents |
| 12/19/2001 | EP0906092B1 Pharmaceutical compositions based on diclofenac |
| 12/19/2001 | EP0885198B1 4-anilinoquinazoline derivatives |
| 12/19/2001 | EP0884948B1 Antiseptic compositions containing chlorobutanol and chlorhexidine |
| 12/19/2001 | EP0859778B1 TETRAHYDROIMIDAZOPYRIDOINDOLEDIONES AS INHIBITORS OF cGMP SPECIFIC PDE |
| 12/19/2001 | EP0854681B1 Therapeutic diet for dogs with lymphoma |
| 12/19/2001 | EP0847391B1 Aromatic compounds and pharmaceutical compositions containing them |
| 12/19/2001 | EP0841899B1 Compositions for topical delivery of active ingredients |
| 12/19/2001 | EP0828742B1 Diazepino-indoles as phosphodiesterase iv inhibitors |
| 12/19/2001 | EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/19/2001 | EP0785794B1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 12/19/2001 | EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 12/19/2001 | EP0781281B1 Beta-carboline derivatives as melatonin agonists, methods for their preparation and their use as drugs |
| 12/19/2001 | EP0766557B1 Topical compositions comprising n-acetyl-l-cysteine |
| 12/19/2001 | EP0751785B2 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 12/19/2001 | EP0728001B1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections |
| 12/19/2001 | EP0721449B1 Inhibitors of beta-amyloid protein production |
| 12/19/2001 | EP0717985B1 Dermatologic preparation |
| 12/19/2001 | EP0707849B1 Use of derivatives of 2,4-disubstituted phenols as 5-lipoxigenase inhibitors |
| 12/19/2001 | EP0703954B1 Polyphenol derivative compositions and preparation thereof |
| 12/19/2001 | EP0683665B1 Magnetically responsive composition for carrying biologically active substances and methods of production and use |
| 12/19/2001 | EP0659073B1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| 12/19/2001 | EP0535021B1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 12/19/2001 | EP0493485B1 Erection-inducing methods and compositions |
| 12/19/2001 | CN1327449A Human cervical cancer 1 protooncogene and protein encoded therein |
| 12/19/2001 | CN1327447A 新药物 New Drug |
| 12/19/2001 | CN1327446A New medicine |
| 12/19/2001 | CN1327444A Alpha 1 beta-adrenergic receptor antagonists |
| 12/19/2001 | CN1327443A Substituted anilides |
| 12/19/2001 | CN1327387A Pharmaceutical formulations in hydroxypropylmenthyl cellulose capsules |
| 12/19/2001 | CN1327386A Anti-HIV infection agents and method for treating HIV infection |
| 12/19/2001 | CN1327385A Anti-bacterial medicinal compositions |
| 12/19/2001 | CN1327384A Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/19/2001 | CN1327382A Improved formulation for topical non-invasive application in vivo |
| 12/19/2001 | CN1327381A Aqueus medicinal compositions |
| 12/19/2001 | CN1326928A Biphenyl sulfonyl amino-cyanogen, its preparing method and use as medicine thereof |
| 12/19/2001 | CN1326786A Anti-cancer medicine composition |
| 12/19/2001 | CN1326781A Varicosis contraction medicine and its preparing method |
| 12/19/2001 | CN1326744A New use of polyunsaturated lecithin |
| 12/19/2001 | CN1326743A Process for preparing 1,3-oxygen-sulphur cyclopentane nucleotide like medicine composition |
| 12/19/2001 | CN1326742A Quick recovery ointment for tinea skin |
| 12/19/2001 | CN1326741A Minocycline vaginal powder |
| 12/19/2001 | CN1326740A Minocycline vaginal solution agent |
| 12/19/2001 | CN1326739A Minocycline vaginal gel |
| 12/19/2001 | CN1326738A Minocycline vaginal effervescent tablets |
| 12/19/2001 | CN1326737A External use medicine for curing sexual disease and its preparing process |
| 12/19/2001 | CN1326736A Method for preparing heame anti-anemina medicine |
| 12/19/2001 | CN1326735A Yangru ofloxacin and its production process |
| 12/19/2001 | CN1326734A Thrombolytic injection for curing cerebral infarction or cerebral thrombus |
| 12/19/2001 | CN1326733A Colon-releasing oral preparation and its preparing method |
| 12/19/2001 | CN1326731A Nicardipine hydro-chloride powder injection and its preparing method |
| 12/19/2001 | CN1076353C Alkyl boronic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/19/2001 | CN1076352C 5-(2-imidazolinylamino) benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agaonists |
| 12/19/2001 | CN1076349C Desoxycyclodepsipeptides and their use for combatting endoparasites |
| 12/19/2001 | CN1076348C 3-bustituted oxindole derivatives as patassium path regulating agent |
| 12/19/2001 | CN1076347C 25-hydroxy-16-one-26.28-bishomo-cholecalciferols |
| 12/19/2001 | CN1076343C Creatine pyruvates and method for their production |
| 12/19/2001 | CN1076199C Clear-heading agent and its prepn. method |
| 12/19/2001 | CN1076197C Medicine for curing mastosis |
| 12/19/2001 | CN1076196C Pharmaceutical composition |
| 12/19/2001 | CN1076195C Compound containing zinc and composition of p-acetaminophenyl acetic acid |
| 12/19/2001 | CN1076194C Pharmaceutical preparation |
| 12/19/2001 | CN1076183C 新的饮料 New beverage |
| 12/19/2001 | CN1076164C Compositions and uses thereof |
| 12/19/2001 | CA2350857A1 The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease |
| 12/18/2001 | USRE37478 1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
| 12/18/2001 | US6331644 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use |
| 12/18/2001 | US6331642 Vitamin D3 analogs |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331637 N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/18/2001 | US6331636 Treatment of central nervous system disorders, diabetes, hypertension, impotency, appetite control |
| 12/18/2001 | US6331635 Taxoids, their preparation and pharmaceutical compositions containing them |
| 12/18/2001 | US6331633 Antidiabetic agents with no liver toxicity |